Credit Suisse Ag Homology Medicines, Inc. Transaction History

Credit Suisse Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.39 - $3.12 $35,346 - $79,338	-25,429 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $2,272 - $3,644	-874 Reduced 3.32%	25,429 $77,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $4,550 - $9,725	1,250 Added 4.99%	26,303 $96,000
Q3 2021 Nov 12, 2021	BUY	$6.01 - $8.71 $16,503 - $23,917	2,746 Added 12.31%	25,053 $196,000
Q2 2021 Aug 16, 2021	BUY	$6.02 - $9.64 $45,541 - $72,926	7,565 Added 51.32%	22,307 $161,000

Q1 2021 May 14, 2021	SELL	$9.17 - $14.8 $93,112 - $150,279	-10,154 Reduced 40.79%	14,742 $139,000
Q4 2020 Feb 12, 2021	BUY	$8.92 - $13.29 $93,660 - $139,545	10,500 Added 72.94%	24,896 $281,000
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $349,271 - $582,939	-35,138 Reduced 70.94%	14,396 $153,000
Q2 2020 Aug 12, 2020	BUY	$12.07 - $19.34 $475,147 - $761,338	39,366 Added 387.16%	49,534 $752,000
Q1 2020 May 13, 2020	SELL	$12.5 - $22.04 $5,112 - $9,014	-409 Reduced 3.87%	10,168 $158,000
Q4 2019 Feb 12, 2020	SELL	$11.42 - $22.19 $1.63 Million - $3.17 Million	-142,817 Reduced 93.1%	10,577 $219,000
Q3 2019 Nov 12, 2019	BUY	$14.74 - $22.28 $1.99 Million - $3.02 Million	135,331 Added 749.22%	153,394 $2.78 Million
Q2 2019 Aug 14, 2019	SELL	$18.35 - $30.34 $97,383 - $161,014	-5,307 Reduced 22.71%	18,063 $353,000
Q1 2019 May 14, 2019	BUY	$19.76 - $29.57 $145,117 - $217,162	7,344 Added 45.83%	23,370 $648,000
Q4 2018 Feb 13, 2019	BUY	$18.39 - $26.3 $294,718 - $421,483	16,026 New	16,026 $358,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.